Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 3001-3010 of 9468

Page
per page
  1. Tryptanthrin
    C5029 Tryptanthrin
    Summary: inhibitor of Cox-2 and 5-LO
      ≤30 mg/mL
  2. Pirlimycin
    C5005 Pirlimycin
    Summary: lincosamide antibiotic
      Soluble in ethanol;Soluble in methanol;Soluble in DMSO;Soluble in dimethyl formamide
  3. 8,11,14-Eicosatriynoic Acid
    C4940 8,11,14-Eicosatriynoic Acid
    Summary: A Cox, 12-LO, and 5-LO inhibitor
      ≤100 mg/mL
  4. GSK2269557
    C5012 GSK2269557
    Summary: inhibitor of PI3Kδ
      ≤0.2 mg/mL
  5. ML-297
    C5045 ML-297
    Summary: Selective Kir3.1/3.2 (GIRK1/2) channel activator
      ≤20 mg/mL
  6. Cinnamycin
    C5021 Cinnamycin
    Summary: tricyclic antibiotic
      Soluble in ethanol;Soluble in DMSO;Soluble in dimethyl formamide
  7. MS37452
    C5042 MS37452
    Summary: competitive inhibitor of CBX7 chromodomain binding to H3K27me3
      ≥49.5 mg/mL
  8. Bufuralol (hydrochloride)
    C5043 Bufuralol (hydrochloride)
    Summary: non-specific β-adrenergic blocker
      ≤15 mg/mL
  9. Ibufenac
    C5048 Ibufenac
    Summary: COX-1 and -2 inhibitor
  10. KP372-1
    C5053 KP372-1
    Summary: specific Akt inhibitor
      ≤20 mg/mL

Items 3001-3010 of 9468

Page
per page